Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bierman

Showing results (151-160 of 253) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Autologous hematopoietic stem cell transplantation for mantle cell lymphomaJ M Vose, P J Bierman, D D Weisenburger, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
British Journal of Haematology|October 1, 2010
Late relapse in patients with diffuse large B-cell lymphomaJulie M Vose, Dennis D Weisenburger, Fausto R Loberiza, et al.
Leukemia & Lymphoma|May 16, 2000
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphomaJ M Vose, D Colcher, L Gobar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group ExperienceA K Ganti, D D Weisenburger, L M Smith, et al.
Blut|July 1, 1987
Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remissionA P Nademanee, S J Forman, G M Schmidt, et al.
British Journal of Haematology|April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II studyJulie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicityJ M Vose, P J Bierman, J R Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2012
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphomaJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.
Pageof 26

Showing results (151-160 of 253) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Autologous hematopoietic stem cell transplantation for mantle cell lymphomaJ M Vose, P J Bierman, D D Weisenburger, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
British Journal of Haematology|October 1, 2010
Late relapse in patients with diffuse large B-cell lymphomaJulie M Vose, Dennis D Weisenburger, Fausto R Loberiza, et al.
Leukemia & Lymphoma|May 16, 2000
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphomaJ M Vose, D Colcher, L Gobar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group ExperienceA K Ganti, D D Weisenburger, L M Smith, et al.
Blut|July 1, 1987
Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remissionA P Nademanee, S J Forman, G M Schmidt, et al.
British Journal of Haematology|April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II studyJulie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicityJ M Vose, P J Bierman, J R Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2012
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphomaJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.
Pageof 26